等待开盘 12-30 09:30:00 美东时间
+0.570
+1.17%
Wall Street's major averages were in the red on Monday as investors sold big technology companies during the last days of the year, including some Mag 7 stocks such as Tesla (TSLA), Meta (META), and A...
12-29 23:25
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
12-17 10:46
Shares of REITs are trading higher after the Fed cut rates, which could drive a...
12-11 04:47
Alexandria Real Estate Equities, Inc. ("Alexandria" or the "Company") (NYSE:ARE) today announced that the Company's Board of Directors authorized a new common stock repurchase program. The new program replaces the
12-08 21:38
今日重点评级关注:摩根士丹利:维持Kyverna Therapeutics"超配"评级,目标价从20美元升至25美元;Maxim Group:维持Capricor Therapeutics"买入"评级,目标价从25美元升至50美元
12-05 08:35
Small-cap stocks powered higher Wednesday as expectations for a rate cut next week strengthened after weaker-than-expected private employment data. The Russell 2000 climbed more than 1% by midday in New York, lifted by rising odds of a 25-basis-point cut at the Fed's Dec. 10 meeting. The CME FedWatch tool shows a 90% chance of a move, with odds of another cut in January near 30%.
12-04 01:46
今日重点评级关注:Benchmark:维持Grupo Televisa"买入"评级,目标价从9美元升至10美元;Truist Securities:维持迪尔股份"买入"评级,目标价从609美元升至612美元
12-01 14:33
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Alexandria业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **核心财务指标表现:** - FFO每股收益(摊薄调整后):第三季度为2.22美元,受入住率下降、西雅图租金收入减少0.03美元以及其他收入较上季度减少870万美元影响 - 租赁活动:第三季度完成120万平方英尺租赁,与五个季度平均水平持平 - 入住率:季度末为90.6%,环比下降20个基点;剔除待售资产影响后,实际入住率环比下降110个基点 - 调整后EBITDA利润率:第三季度为71%,与五年平均水平保持一致 - 其他收入:第三季度为1600万美元,与过去8个季
12-01 12:26
Evercore ISI Group analyst Steve Sakwa maintains Alexandria Real Estate (NYSE:ARE) with a Outperform and lowers the price target from $74 to $72.
11-28 23:37
During times of turbulence and uncertainty in the markets, many investors turn ...
11-21 00:46